ETNB
Price
$14.80
Change
+$0.04 (+0.27%)
Updated
Oct 20, 04:59 PM (EDT)
Capitalization
2.19B
17 days until earnings call
Intraday Buy/Sell Signals
PLRX
Price
$1.64
Change
+$0.06 (+3.82%)
Updated
Oct 20, 04:59 PM (EDT)
Capitalization
96.38M
22 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

ETNB vs PLRX

Header iconETNB vs PLRX Comparison
Open Charts ETNB vs PLRXBanner chart's image
89bio
Price$14.80
Change+$0.04 (+0.27%)
Volume$85.72K
Capitalization2.19B
Pliant Therapeutics
Price$1.64
Change+$0.06 (+3.82%)
Volume$19.06K
Capitalization96.38M
ETNB vs PLRX Comparison Chart in %
ETNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ETNB vs. PLRX commentary
Oct 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETNB is a Hold and PLRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 21, 2025
Stock price -- (ETNB: $14.76 vs. PLRX: $1.57)
Brand notoriety: ETNB and PLRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ETNB: 33% vs. PLRX: 50%
Market capitalization -- ETNB: $2.19B vs. PLRX: $96.38M
ETNB [@Biotechnology] is valued at $2.19B. PLRX’s [@Biotechnology] market capitalization is $96.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ETNB’s FA Score shows that 1 FA rating(s) are green whilePLRX’s FA Score has 0 green FA rating(s).

  • ETNB’s FA Score: 1 green, 4 red.
  • PLRX’s FA Score: 0 green, 5 red.
According to our system of comparison, ETNB is a better buy in the long-term than PLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ETNB’s TA Score shows that 4 TA indicator(s) are bullish while PLRX’s TA Score has 4 bullish TA indicator(s).

  • ETNB’s TA Score: 4 bullish, 5 bearish.
  • PLRX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PLRX is a better buy in the short-term than ETNB.

Price Growth

ETNB (@Biotechnology) experienced а -0.27% price change this week, while PLRX (@Biotechnology) price change was +6.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.76%. For the same industry, the average monthly price growth was +18.12%, and the average quarterly price growth was +72.90%.

Reported Earning Dates

ETNB is expected to report earnings on Nov 06, 2025.

PLRX is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+4.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ETNB($2.19B) has a higher market cap than PLRX($96.4M). ETNB YTD gains are higher at: 88.747 vs. PLRX (-88.079). PLRX has higher annual earnings (EBITDA): -201.76M vs. ETNB (-442.86M). ETNB has more cash in the bank: 561M vs. PLRX (263M). ETNB has less debt than PLRX: ETNB (37.6M) vs PLRX (60.4M). ETNB (0) and PLRX (0) have equivalent revenues.
ETNBPLRXETNB / PLRX
Capitalization2.19B96.4M2,274%
EBITDA-442.86M-201.76M220%
Gain YTD88.747-88.079-101%
P/E RatioN/AN/A-
Revenue00-
Total Cash561M263M213%
Total Debt37.6M60.4M62%
FUNDAMENTALS RATINGS
ETNB: Fundamental Ratings
ETNB
OUTLOOK RATING
1..100
93
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
18

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ETNBPLRX
RSI
ODDS (%)
Bearish Trend 4 days ago
87%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
85%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
82%
Bullish Trend 4 days ago
79%
MACD
ODDS (%)
Bearish Trend 4 days ago
80%
Bullish Trend 4 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
75%
Advances
ODDS (%)
Bullish Trend 15 days ago
85%
Bullish Trend 6 days ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 14 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
88%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ETNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
COFYX41.690.21
+0.51%
Columbia Contrarian Core Inst3
CAAIX41.850.13
+0.31%
Ariel Appreciation Institutional
TEFRX9.30N/A
N/A
Templeton Foreign R
KMKCX73.32-0.47
-0.64%
Kinetics Market Opportunities Adv C
KGLCX15.69-0.15
-0.95%
Kinetics Global Adv C

PLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with OCUL. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLRX
1D Price
Change %
PLRX100%
-4.85%
OCUL - PLRX
42%
Loosely correlated
-2.95%
ITRM - PLRX
41%
Loosely correlated
-3.86%
FHTX - PLRX
40%
Loosely correlated
-7.42%
LXRX - PLRX
38%
Loosely correlated
-3.40%
SLDB - PLRX
37%
Loosely correlated
-4.55%
More